Sanjivani Paranteral Limited (BOM:531569)
India
· Delayed Price · Currency is INR 170.55
+0.55 (0.32%)
At close: Mar 9, 2026
Sanjivani Paranteral Revenue
Sanjivani Paranteral had revenue of 220.63M INR in the quarter ending December 31, 2025, with 27.17% growth. This brings the company's revenue in the last twelve months to 736.34M, up 13.67% year-over-year. In the fiscal year ending March 31, 2025, Sanjivani Paranteral had annual revenue of 700.99M with 28.83% growth.
Revenue (ttm)
736.34M
Revenue Growth
+13.67%
P/S Ratio
2.85
Revenue / Employee
18.41M
Employees
40
Market Cap
2.10B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 700.99M | 156.88M | 28.83% |
| Mar 31, 2024 | 544.11M | 189.19M | 53.31% |
| Mar 31, 2023 | 354.92M | 48.79M | 15.94% |
| Mar 31, 2022 | 306.13M | 55.13M | 21.96% |
| Mar 31, 2021 | 251.00M | 87.44M | 53.46% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BDH Industries | 847.44M |
| Ambalal Sarabhai Enterprises | 2.03B |
| Oxygenta Pharmaceutical | 1.13B |
| Kerala Ayurveda | 1.27B |
| Astonea Labs | 1.17B |
| Sat Kartar Life | 1.63B |
| Gennex Laboratories | 1.52B |
| Coral Laboratories | 875.55M |
Sanjivani Paranteral News
- 20 days ago - Q3 2026 Sanjivani Paranteral Ltd Earnings Call Transcript - GuruFocus
- 3 months ago - Q2 2026 Sanjivani Paranteral Ltd Earnings Call Transcript - GuruFocus